In this four-minute video Dr H Richard Alexander professor of surgery at the University of Maryland School of Medicine and surgical oncologist at the University of Maryland Greenebaum Cancer Center discusses the difficulty of developing a successful standardized treatment for a rare disease known as malignant peritoneal mesothelioma Dr Alexander talks about ongoing research to improve available treatment options for this condition including his teams discovery of special proteins that appear to predict the growth of tumors associated with this illness and how developing targeted therapies for these proteins could affect the treatment of other known cancers
Related Links
University of Maryland Greenebaum Comprehensive Cancer Center Oncology Program Oncology Program Education
